Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy.
Vitamin D as a protective factor in multiple sclerosis.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.
Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.
Purines in neurodegeneration and neuroregeneration.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
The effect of rhythmic-cued motor imagery on walking, fatigue and quality of life in people with multiple sclerosis: A randomised controlled trial.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
[Natalizumab as induction therapy in multiple sclerosis.]
Why this is not multiple sclerosis: a case based approach.
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.
Fingolimod May Protect Neurons from Degeneration
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.

Pages